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Numerous studies have been reported concern-
ing the metabolic status of psoriatics (1—19).
These investigations have not always been car-
ried out under carefully controlled conditions,
and many of the results reported are open to
question. In many instances, subsequent studies
by different investigators have contradicted the
findings reported previously.
This has been particularly true of studies on
lipid distribution in psoriasis. Grutz and Burger
(10) reported an increase in the total lipids of
psoriatic serum. This finding was supported by
the work of Levy-Franckel and Breant (11) and
Versari (12). Incedayi and Ottenstein (13) have
also suggested a relationship between psoriasis
and abnormal lipid metabolism. Rosen et al. (15)
studied lipid partitions in 130 psoriatic patients,
and found a tendency toward hypocholestero-
lemia. Madden (16) could find no significant
differences in serum cholesterol levels between
psoriatic and normal individuals. Castro-Men-
doza et al. (17) likewise found no evidence for a
disturbance of lipid metabolism accompanying
psoriasis.
With respect to lipid metabolism in psoriasis,
therefore, published reports indicate (1) an ele-
vation in serum lipids, including cholesterol;
(2) cholesterol levels below normal; and (3) no
abnormalities in lipid levels. The need for a
re-investigation of this problem becomes obvious.
Since the role of serum proteins and lipopro-
teins in lipid transport has been clearly demon-
strated, the possibility suggested itself that a
study of blood lipid levels in psoriasis would be
of greater value if serum proteins and lipopro-
teins were studied simultaneously.
Serum proteins in psoriasis have been investi-
gated previously. In 1944, Mulvehill (14) studied
total protein levels and albumin/globulin ratios
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in psoriatic serum. These values were within the
normal range in the patients studied. Lever et al.
(18) carried out an electrophoretic analysis on
the serum of six psoriatic individuals. These
workers (18) reported a moderately increased
a1- and a2-globulin, and in some cases a moder-
ately decreased total serum protein.
Comparatively little work has been done on
lipoprotein levels in psoriasis. Meneghini et al.
(19), using paper electrophoresis, reported an
increase in 3-lipoprotein, and a slight decrease in
a-lipoprotein in 50% of the psoriatic patients
studied.
In view of the conflicting data appearing in
the literature on serum lipid levels in psoriasis,
we have undertaken to reinvestigate the problem.
Serum lipid partitions have been carried out on
psoriatic patients. In addition, the serum was
subjected to free moving boundary electro-
phoresis, and to analytical ultracentrifugation.
An attempt was made to correlate the values
obtained in the lipid partitions with these other
findings.
PLAN OF STUDY
Eighteen patients (13 males and 5 females)
with active psoriasis, ranging in age from 23 to
55 years, were studied in this investigation. Ten
normal control subjects were also studied. The
psoriatic patients included in this study were
subjected to complete physical examinations,
and to comprehensive laboratory studies, in
order to rule out the possibility of renal or liver
disease. These studies included complete blood
counts, serology, and chest x-rays. The liver
function tests consisted of eephalin-flocculation,
serum bilirubin, and B. S. P. tests. Renal func-
tion tests included P. S. P. tests, nonprotein
nitrogen determinations, 24 hour creatinine clear-
ance tests, and routine urinalysis. The results of
all these tests were found to be within the normal
range in each individual included in this study.
In addition, each patient was given a thorough
examination of cardiovascular function. Thirteen
patients showed no evidence of any cardiovascu-
lar disorder. In the remaining five patients, there
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TABLE I
Serum lipid partitions in psoriatics and in normal
subjects
Subject Age
Psoria-
tics
Sex
M
M
M
F
M
M
F
F
M
M
M
M
M
M
M
F
F
M
Total
Lipids
mgm. %
628
663
798
685
669
903
590
680
1001
725
498
1321
725
818
983
732
743
660
yrs.
43
27
39
55
40
47
25
23
26
28
31
31
45
55
46
43
33
24
Total
Choles-
terol
sugm. %
175
176
277
216
196
339
198
218
288
186
174
296
243
294
286
243
247
196
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Choles-
terol
Esters
%
77
75
75
72
70
65
75
74
72
73
73
70
72
73
69
73
68
72
Phospho-
lipids
mgsn. %
231
216
276
260
224
330
217
226
306
221
206
335
239
271
296
240
253
247
was some evidence for cardiovascular disorder.
This point will be discussed in more detail later.
All blood samples were drawn with the patients
in a fasting state. No special diets were given.
The psoriatie patients were receiving no sys-
temic medications at the time this study was
initiated.
METHODS
Total lipids were determined by the method of
Bragdon (20), total cholesterol and cholesterol
esters by the Schoenheimer-Sperry method (21),
and phospholipids by the Fiske-SubbaRow
method (22).
Free moving boundary electrophoresis was
carried out in veronal buffer, at pH 8.6 and ionic
strength 0.1, according to the procedure de-
scribed by Tiselius (23). Serum protein com-
ponents were quantitated by the method of
Tiselius and Kabat (24).
Lipoproteins were determined by ultraccn-
trifugation at a density of 1.21 by the Lewis,
Green and Page modification (25) of Gofman's
technique (26).
RESULTS
Serum Lipid Partitions: Results of the serum
lipid determinations on the 18 psoriatic patients,
and on 10 control subjects are recorded in
Table I. Thirteen of the psoriatic patients showed
no abnormalities in total fats, total cholesterol,
cholesterol esters, or phospholipids. In 4 pa-
tients ( 6, 9, 12, 15), total lipids, total choles-
terol, and phospholipids were all elevated. One
additional patient (* 14) had a slightly elevated
total cholesterol.
Electrophoretic Analysis: Results of the dcc-
trophoretic studies are recorded in Table II.
There were no significant abnormalities in total
protein, albumin, or in total globulins. In one
case (15), the A/G ratio was low. All of the
globulin fractions (ai, am, 3, and 'I') were within
the normal range in 8 of the psoriatic patients
studied. Six other patients showed slight abnor-
malities in only one fraction. Three patients
showed abnormalities in a-globulin fractions.
Only one patient showed abnormalities in
3 fractions.
Considering the data from Table II in terms
of the protein fractions: one patient (3) had a
somewhat elevated a1-globulin, in 4 patients
(9, 11, 12, 17) this value was below normal
Normals
1 21 M 551 171 68 210
2 56 F 650 185 74 224
3 58 M 859 257 79 250
4 27 M 778 278 70 253
5 27 F 605 168 74 214
6 50 M 856 268 71 278
7 40 F 779 225 72 275
8 34 M 647 186 69 216
9 30 F 637 195 76 227
10 19 M 426 141 73 182
Normal Range.... 425—860 140—240 68—79 180—280
four patients (1, 6, 13, 15) had an elevated
am-globulin, one patient ( 11), a decreased
a2-globulin; one patient (l4) had an elevated
$-globulin, two (11, 17) had low values for
3-globulin; two patients ( 12, 15) had somewhat
elevated y-globulin levels. In no case were any
of these abnormalities of great magnitude.
Although there is some variation from normal
in the serum protein patterns of these psoriatic
individuals, there is no consistency with respect
to the protein fractions affected.
In 3 of these patients (see Table II, 4, 5, 12),
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TABLE III
Lipo protein analysis on psoriatic patients, density 1.21
Subject Age -S 70—400 -S 40—70 -S 25—40 -S 20—25 -S 1—10
Normal Values
yrs.
18—35
mg./100 ml.
38 4
mg/lOU ml.
24 2
rng./100 ml.
244 28
mg./lOO ml.
12 1
mg./l00 ml.
179 5
Normal Values 35—60 60 10 33 1 285 17 14 1 180 5
Psoriatics
1 43 53 24 293 7 174
2 27 41 22 269 11 123
3 39 28 24 278 15 209
6 47 126 135 399 12 236
9 26 183 55 332 12 172
10 28 60 36 167 15 167
11 31 66 36 186 5 234
12 31 209 98 296 21 167
18 24 51 26 213 9 140
the electrophoretic analyses were repeated at a
time when the psoriasis was in an inactive stage.
It can be seen from Table II that there was no
significant variation in electrophoretie results
between the two experiments.
Lipoprotein. Determinations: Results of the
lipoprotein analyses on 9 of the male psoriatic
patients are recorded in Table III. Two (2, 18)
of the patients studied showed no abnormalities
in any lipoprotein fraction. Two patients (10,
Subject
TABLE II
Eleetrophoretic studies on the serum of
Age Sex Total Protein A/G Ratio
patients with psoriasis
Albumin
Globulin
Total Alpha 1 Alpha 2
% %
3.5—4.5 7—10Normal
Range
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
yrs.
43
27
39
55
40
47
25
23
26
28
31
31
45
55
46
43
33
19
gms. %
6.5—8.5
6.21
6.83
6.26
6.62
7.23
6.05
7.07
7.02
6.77
6.40
6.68
6.77
6.49
8.09
7.23
6.31
6.88
6.59
5.74
6.44
7.20
M
M
M
F
M
M
F
F
M
M
M
M
M
M
M
F
F
M
1.5—3.0
1 .46
2.08
1.46
1.67
1.70
2.06
1.94
1.34
1.68
2.06
2.08
2.10
2.80
1.38
1.79
1.63
1.42
1.17
1 .68
2.22
1.96
%
60—66
59.4
67.5
59.3
62.5
62.8
67.2
66.0
57.1
62.5
67.1
67.4
67.6
73.7
57.9
63.0
62.0
58.8
53.3
62.8
68.9
61.2
%
34—40
40.6
32.5
40.7
37.5
37.2
32.8
34.0
42.9
37.5
32.9
32.6
32.4
26.3
42.1
37.0
38.0
41.2
46.7
37.2
31.1
38.8
Beta
%
12—17
14.0
14.4
16.7
11.7
11.7
13.4
12.3
17.4
11.6
12.0
15.3
11.4
10.4
12.7
14.1
13.6
19.0
14.2
14.6
10.9
14.5
5.2
2.9
5.4
4.0
4.3
3.0
3.3
3.1
3.9
3.9
2.4
3.0
1.9
3.4
2.5
4.4
2.8
3.9
3.4
2.1
3.8
Gamma
%
8—14
10.0
7.7
8.1
12.5
14.0
8.5
9.8
10.4
14.4
7.6
7.7
11.4
8.1
16.2
12.1
7.9
9.8
16.6
12.4
9.7
12.3
11.4
7.5
10.5
9.3
7.2
7.9
8.6
12.0
7.6
9.4
7.2
6.6
5.9
9.8
8.2
12.1
9.6
12.0
6.8
8.4
8.2
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11) had elevations only in the -S 70—400 fraction.
One patient (9) had elevations only in the
-S 70—400 and 40—70 fractions. It should be
noted here that the -S 40—70 fractions corre-
spond to 3-lipoprotein. One patient (*1) showed
values below normal in the -S 40—70 and 20—25
fractions, One patient (3) showed abnormali-
ties in 3 fractions, -S 70—400 and 40—70 were
somewhat low, while the -S 1—10 fraction was
slightly elevated. Two patients had elevations in
4 fractions; patient (6) in the -S 70—400, 40—70,
25—40, and 1—10 fractions; patient ( 12) in the
-S 70—400, 40—70, 25—40, and 20—25 fractions.
Thus, there were abnormalities in the -S 70—
400 fraction in 6 cases, in the -S 40—70 fraction
in 5 cases, in the -S 25—40 fraction in 2 cases, in
the -S 20—25 fraction in 2 cases, and in the -S
1—10 fraction in 2 cases.
DISCUSSION
Although some abnormalities were obtained
in the determinations carried out in this study,
these abnormalities are not striking. The data
presented in Table I might be interpreted to
indicate that total lipids and/or total cholesterol
were elevated in a significant number of psori-
atics. If one considers the lipid data in connec-
tion with the serum protein and lipoprotein
data, and with the clinical findings, a different
interpretation is presented. In Table IV, this
correlation is made for the 5 patients found to
have elevated total lipids and/or total cholesterol.
It can be seen from Table IV that an elevation
in these lipid fractions is accompanied either by
an elevated 9-g1obu1in or an elevated -lipopro-
tein, or both.
These changes, considered together, are con-
sistent with results obtained on atherosclerotic
patients. If the data presented in Table IV are
further correlated with the clinical findings rela-
tive to this disease, it can be seen that in all of
the 5 patients with elevated lipids, a diagnosis
of latent or overt atherosclerosis can be sub-
stantiated. Three of the subjects exhibiting
atherosclerotic changes belonged to the 40—50
year age group, one to the 30—40 year age group,
and one to the 20—30 year age group.
All of the lipid elevations might therefore be
accounted for on the basis of the clinical findings
relative to atherosclerosis. There is no evidence,
on the basis of the work presented here, to indi-
cate that psoriasis is accompanied by abnormal
serum lipid levels.
There is also no correlation between the elec-
trophoretic and ultra-centrifugal findings and
the existence of psoriasis. Abnormalities demon-
TABLE IV
Correlation of serum lipid, protein, and lipoproteirt analyses with cardiovascular symptoms in psoriatic
patients with abnormal serum lipid levels
Subject Age Sex T ILipids
Total
Choles- Electrophoresis
.
Ultracentrifugation Clinical Data
yrs. mgm. % mgm. %
6 47 M 903 339 Elevated a2
globulin
Elevated j3
lipopro-
tein
Previous myocardial infarction
EKG changes of ischemia
Increased diastolic pressure
9 26 M 1001 288 Normal Elevated
lipopro-
tein
Strong familial history of cardiovas-
cular disease
Retinal arteriolar sclerosis
Thickened brachial and temporal
arteries
12 31 M 1321 296 Normal Elevated 3
lipopro-
tein
Familial history of cardiovascular
disease
Retinal arteriolar sclerosis
14 55 M 818 294 Elevated fi
globulin
— Angina pectoris
Increased diastolic pressure
Retinal arteriolar sclerosis
15 46 M 983 286 Elevated as
globulin
— Increased diastolic pressure
? Angina pectoris
Retinal arteriolar sclerosis
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strated were not of great magnitude, and showed
no consistency.
SUMMARY
Serum lipid partitions, electrophoretic analyses,
and ultracentrifugal analyses were carried out on
a number of psoriatic patients. The elevations in
serum lipid levels could be attributed to the
presence of latent or overt atherosclerosis. There
was no significant correlation between abnormali-
ties in lipid levels, serum proteins and lipopro-
teins, and the existence of psoriasis.
The authors would like to thank Dr. A. C.
Curtis for his interest in this investigation, and
in the preparation of the manuscript.
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